Kuano

About:

Kuano provides innovative quantum and AI solutions for drug discovery and design.

Top Investors: Creative Destruction Lab (CDL), Innovate UK, Mercia Ventures, Ascension Ventures, ACF Investors

Description:

Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.

Total Funding Amount:

2.8M GBP

Headquarters Location:

London, England, United Kingdom

Founded Date:

2020-01-01

Contact Email:

contact(AT)kuano.ai

Founders:

David Wright, Jarryl D'Oyley, Parminder Ruprah, Vid Stojevic

Number of Employees:

11-50

Last Funding Date:

2023-09-12

IPO Status:

Private

Industries: